Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D05KWF
|
||||
| Former ID |
DNC013865
|
||||
| Drug Name |
Cudraxanthone M
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Discovery agent | Investigative | [530017] | ||
| Formula |
C23H24O6
|
||||
| Canonical SMILES |
CC1C(C2=C(O1)C=C3C(=C2O)C(=O)C4=CC(=C(C(=C4O3)CC=C(C)C)<br />O)O)(C)C
|
||||
| InChI |
1S/C23H24O6/c1-10(2)6-7-12-19(25)14(24)8-13-20(26)17-15(29-22(12)13)9-16-18(21(17)27)23(4,5)11(3)28-16/h6,8-9,11,24-25,27H,7H2,1-5H3
|
||||
| InChIKey |
ZYJVDWWKUSJAQY-UHFFFAOYSA-N
|
||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | Neuraminidase | Target Info | Inhibitor | [530017] | |
| KEGG Pathway | Other glycan degradation | ||||
| References | |||||